De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay

Shuying Cai1,2, Jinliang Li1, Ye Wu1

  • 1Department of Pediatrics, Peking University First Hospital, Peking, 100034, China.

Insights

De novo variants in TUBB2A gene are associated with infantile-onset epilepsy and global developmental delay. These TUBB2A mutations often lead to brain malformations like cortical and corpus callosum dysplasia.

Area of Science:

  • Neurogenetics
  • Developmental Neuroscience
  • Epileptology

Background:

  • TUBB2A gene mutations are increasingly recognized as a cause of neurodevelopmental disorders.
  • Infantile-onset epilepsy and global developmental delay are significant clinical manifestations.

Observation:

  • Two new cases of infantile-onset epilepsy with global developmental delay due to de novo TUBB2A variants are presented.
  • Literature review identified a total of nine patients with TUBB2A mutations, exhibiting a spectrum of neurological and neuroimaging findings.
  • Common findings include developmental delay, epilepsy, cortical dysplasia, and corpus callosum abnormalities.

Findings:

  • De novo variants in TUBB2A are linked to infantile-onset epilepsy and global developmental delay.
  • Brain MRI often reveals cortical dysplasia and corpus callosum abnormalities.
  • The p.A248V mutation is the most frequent, with consistent phenotypes including global developmental delay and corpus callosum dysplasia.

Implications:

  • The study highlights TUBB2A as a crucial gene in early neurodevelopment.
  • Understanding TUBB2A mutation hotspots may aid in diagnosing and managing related neurodevelopmental disorders.
  • Further research into genotype-phenotype correlations can refine diagnostic and therapeutic strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
633
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K